Found 0 matching trials
Clinical, Anti-Inflammatory And Anti-Infective Properties Of Amniotic Membranes Used For Guided Tissue Regeneration PHASE3 The objective of this study is to evaluate the anti-inflammatory and anti-i...
Show More Location
SVS Institute of Dental Sciences, Mahabubnagar
Learn More & Join Trial
YES Study - Newly Diagnosed/Metastatic Intervention NA This research study is being done to monitor common symptoms and behavior, ...
Show More Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Learn More & Join Trial
Gamma Delta T Cells in AML N/A The Royal Marsden NHS Foundation Trust is committed to improving patient ex...
Show More Location
The Royal Marsden NHS Foundation Trust
Learn More & Join Trial
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation PHASE1 Patients undergoing semi-elective lower extremity major amputation from com...
Show More Location
Indiana University
Learn More & Join Trial
KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models N/A This study will assess the ability of the Known Medicine platform to predic...
Show More Learn More & Join Trial
Changes Associated With H. Pylori and Gastric Carcinogenesis N/A This is a research study for patients who currently have or previously had ...
Show More Status
Active Not Recruiting
Location
Weill Cornell Medical College
Learn More & Join Trial
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01) N/A This study is referred to as the "umbrella master protocol" for pembrolizum...
Show More Location
Banner MD Anderson Cancer Center ( Site 0001)
Learn More & Join Trial
PRODIGE 90 - (FFCD 2204) Neoadjuvant Dostarlimab with Short Course Radiotherapy in a Watch-and-wait Strategy for Microsatellite Unstable or Mismatch Repair-deficient Locally Advanced Rectal Cancer Patients PHASE3 Total neoadjuvant treatment (TNT) including radiotherapy and induction or c...
Show More Location
CHU Dijon Bourgogne
Learn More & Join Trial
Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN) PHASE1 This is a single-center cross-sectional imaging and correlative biomarker s...
Show More Location
Stanford Hospital and Clinics
Learn More & Join Trial
Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging N/A With stress echo (SE) 2020 study, a new standard of practice in stress imag...
Show More Location
Fatebenefratelli Hospital
Learn More & Join Trial